Search - tctmd.com

Displaying 501 - 520 of 1163

Sort: Relevancy | Date

Presentation TVT 2022

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

Presenter: Yasser Radwan

June 09, 2022

Presentation TVT 2022

High Post-TAVR Gradient: Etiology and Outcomes

Presenter: Philippe Pibarot

June 08, 2022

Presentation TVT 2022

Prognosticating With Imaging, Part 2: Refining the Optimal Timing of AS Intervention With Echocardiography

Presenter: Enrique Garcia-Sayan

June 08, 2022

Presentation TVT 2022

Prognosticating With Imaging, Part 1: Leveraging TAVR CT Analysis for Patient Risk Stratification

Presenter: Joao Cavalcante

June 08, 2022

Presentation TVT 2022

CT Planning for Challenging TAVR Indications: Bicuspid, Preventing Coronary Obstruction, Valve-in-Valve

Presenter: Philipp Blanke

June 08, 2022

Presentation TVT 2022

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Presenter: Martin Leon

June 08, 2022

Presentation TVT 2022

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Presenter: Vijay Iyer

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2022

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

Presenter: Haim Danenberg

June 08, 2022

Presentation TVT 2022

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

Presentation TVT 2022

Beyond Aortic Stenosis: TAVR Outside the Box

Presenter: Marissa Munsayac

June 08, 2022

Presentation ACC 2022

Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis: The FLAVOUR Randomized Clinical Trial

Presenter: Bon-Kwon Koo

April 04, 2022

Presentation THT 2022

Valvular Cardiogenic Shock - Evaluating the Mechanism of Prosthetic Mitral Valve Stenosis

Presenter: Peter Hanna

February 02, 2022

Presentation Controversies and Advances 2021

UPSTREAM management of aortic stenosis

Presenter: Martin B. Leon

December 03, 2021

Presentation Controversies and Advances 2021

Treating Stenosis or Ischemia Does Not Improve Clinical Outcomes – Medical Therapy Is King (and Queen)

Presenter: William E. Boden

December 03, 2021

Presentation TCT 2021

Case Presentation 1 Case: Vulnerable Stenosis by CTA, but FFR Negative or Borderline (From Dr. Koo); Vulnerable Stenosis by OCT/IVUS/NIRS/s Ischemia (From Dr. Erlinge)

Presenter: Jeehoon Kang

November 06, 2021

Presentation TCT 2021

TCT 598: Pulmonary Vein Stenosis Secondary to Fibrosing Mediastinitis With Hemodynamic Assessment Before and After Stenting

Presenter: Brenden Ingraham

November 06, 2021

Advertisement

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

High Post-TAVR Gradient: Etiology and Outcomes

Prognosticating With Imaging, Part 2: Refining the Optimal Timing of AS Intervention With Echocardiography

Prognosticating With Imaging, Part 1: Leveraging TAVR CT Analysis for Patient Risk Stratification

CT Planning for Challenging TAVR Indications: Bicuspid, Preventing Coronary Obstruction, Valve-in-Valve

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Beyond Aortic Stenosis: TAVR Outside the Box

Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis: The FLAVOUR Randomized Clinical Trial

Valvular Cardiogenic Shock - Evaluating the Mechanism of Prosthetic Mitral Valve Stenosis

UPSTREAM management of aortic stenosis

Treating Stenosis or Ischemia Does Not Improve Clinical Outcomes – Medical Therapy Is King (and Queen)

Case Presentation 1 Case: Vulnerable Stenosis by CTA, but FFR Negative or Borderline (From Dr. Koo); Vulnerable Stenosis by OCT/IVUS/NIRS/s Ischemia (From Dr. Erlinge)

TCT 598: Pulmonary Vein Stenosis Secondary to Fibrosing Mediastinitis With Hemodynamic Assessment Before and After Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content